News
Impeto’s SUDOSCAN technology for monitoring peripheral neuropathies is included in Withings’ recently announced Body Scan smart scale.
Silicon Valley Bank report predicts VCs will slow down their deal pace in 2022.
MConnekt assists healthcare practitioners to find clients and optimise workflow.
This news comes just months after Exscientia went public.
The company plans to use the funding to expand its commercial team, scale operations and develop new products.
The test reports on the G84E mutation in the HOXB13 gene, which studies have shown increase a person’s risk of developing prostate cancer.
Users can tap into the system to measure their blood pressure, heart rate, heart variability rate and more.
The UAE-based asset owner and investor has announced it is to consolidate several healthcare companies within Pure Health.
MobiHealthNews rounds up all of the new digital health technologies released at CES this year.
The growth of telehealth and remote-monitoring tools could be a game-changer for women's health, particularly maternal and fetal care.